🇨🇦 SB-1121(2) in Canada

SB-1121(2) (SB-1121(2)) regulatory status in Canada.

Marketing authorisation

SB-1121(2) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Canada

Frequently asked questions

Is SB-1121(2) approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for SB-1121(2) in Canada?

Nguyen Thi Trieu, MD is the originator. The local marketing authorisation holder may differ — check the official source linked above.